These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 27399687)

  • 1. Dual-Labeled Near-Infrared/(99m)Tc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells.
    Yamaguchi H; Tsuchimochi M; Hayama K; Kawase T; Tsubokawa N
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER2-Targeted Multifunctional Silica Nanoparticles Specifically Enhance the Radiosensitivity of HER2-Overexpressing Breast Cancer Cells.
    Yamaguchi H; Hayama K; Sasagawa I; Okada Y; Kawase T; Tsubokawa N; Tsuchimochi M
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of
    Rainone P; Riva B; Belloli S; Sudati F; Ripamonti M; Verderio P; Colombo M; Colzani B; Gilardi MC; Moresco RM; Prosperi D
    Int J Nanomedicine; 2017; 12():3447-3461. PubMed ID: 28496321
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Rainone P; De Palma A; Sudati F; Roffia V; Rigamonti V; Salvioni L; Colombo M; Ripamonti M; Spinelli AE; Mazza D; Mauri P; Moresco RM; Prosperi D; Belloli S
    Int J Nanomedicine; 2021; 16():1943-1960. PubMed ID: 33727808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
    Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
    J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of HER2-Positive Tumors in NOD/SCID Mice with Pertuzumab Fab-Hexahistidine Peptide Immunoconjugates Labeled with [
    Facca VJ; Al-Saden N; Ku A; Reilly RM
    Mol Imaging Biol; 2021 Aug; 23(4):495-504. PubMed ID: 33479914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Modality Noninvasive Mapping of Sentinel Lymph Node by Photoacoustic and Near-Infrared Fluorescent Imaging Using Dye-Loaded Mesoporous Silica Nanoparticles.
    Liu Z; Rong P; Yu L; Zhang X; Yang C; Guo F; Zhao Y; Zhou K; Wang W; Zeng W
    Mol Pharm; 2015 Sep; 12(9):3119-28. PubMed ID: 26132789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preclinical application of MR and fluorescent dual-modality imaging combined with photothermal therapy in HER-2 positive breast cancer].
    Luo XJ; Li J; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):587-593. PubMed ID: 30139028
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of the Tumor-Specific Antigen-Derived Synthetic Peptides as Potential Candidates for Targeting Breast and Other Possible Human Carcinomas.
    Okarvi SM; AlJammaz I
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31470531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of hapten-specific scFv from a phage display library and applications for HER2-positive tumor imaging.
    Kim HY; Wang X; Wahlberg B; Edwards WB
    Bioconjug Chem; 2014 Jul; 25(7):1311-22. PubMed ID: 24898150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe
    Li L; Wu Y; Wang Z; Jia B; Hu Z; Dong C; Wang F
    J Nucl Med; 2017 May; 58(5):821-826. PubMed ID: 28104744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and
    Okarvi SM; Aljammaz I
    Anticancer Res; 2018 May; 38(5):2823-2830. PubMed ID: 29715105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Evaluation of
    Oroujeni M; Rinne SS; Vorobyeva A; Loftenius A; Feldwisch J; Jonasson P; Chernov V; Orlova A; Frejd FY; Tolmachev V
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific aptamer-conjugated mesoporous silica-carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy.
    Wang K; Yao H; Meng Y; Wang Y; Yan X; Huang R
    Acta Biomater; 2015 Apr; 16():196-205. PubMed ID: 25596325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores.
    Sano K; Mitsunaga M; Nakajima T; Choyke PL; Kobayashi H
    Breast Cancer Res; 2012; 14(2):R61. PubMed ID: 22510481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalized polymeric nanoparticles loaded with indocyanine green as theranostic materials for targeted molecular near infrared fluorescence imaging and photothermal destruction of ovarian cancer cells.
    Bahmani B; Guerrero Y; Bacon D; Kundra V; Vullev VI; Anvari B
    Lasers Surg Med; 2014 Sep; 46(7):582-92. PubMed ID: 24961210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
    Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM
    J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors.
    Tran T; Engfeldt T; Orlova A; Sandström M; Feldwisch J; Abrahmsén L; Wennborg A; Tolmachev V; Karlström AE
    Bioconjug Chem; 2007; 18(6):1956-64. PubMed ID: 17944527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
    Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
    World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoporous silica-coated gold nanorods with embedded indocyanine green for dual mode X-ray CT and NIR fluorescence imaging.
    Luo T; Huang P; Gao G; Shen G; Fu S; Cui D; Zhou C; Ren Q
    Opt Express; 2011 Aug; 19(18):17030-9. PubMed ID: 21935063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.